Media Kobo, Inc. (TYO:3815)
606.00
-3.00 (-0.50%)
Aug 13, 2025, 3:30 PM JST
Elevation Oncology Income Statement
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2016 - 2020 |
Revenue | 1,916 | 2,012 | 2,073 | 2,203 | 1,929 | 1,798 | Upgrade |
Revenue Growth (YoY) | -7.03% | -2.94% | -5.90% | 14.20% | 7.29% | -7.46% | Upgrade |
Cost of Revenue | 957 | 1,012 | 1,005 | 1,087 | 1,039 | 962 | Upgrade |
Gross Profit | 959 | 1,000 | 1,068 | 1,116 | 890 | 836 | Upgrade |
Selling, General & Admin | 1,111 | 1,064 | 1,009 | 922 | 840 | 846 | Upgrade |
Other Operating Expenses | 74 | 74 | - | - | - | - | Upgrade |
Operating Expenses | 1,188 | 1,141 | 1,009 | 922 | 842 | 846 | Upgrade |
Operating Income | -229 | -141 | 59 | 194 | 48 | -10 | Upgrade |
Interest Expense | -19 | -11 | -10 | -12 | -13 | -11 | Upgrade |
Interest & Investment Income | 5 | 4 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 1 | - | -1 | -1 | 4 | 3 | Upgrade |
EBT Excluding Unusual Items | -242 | -148 | 48 | 181 | 39 | -18 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -8 | -1 | -3 | - | Upgrade |
Asset Writedown | -15 | -89 | - | -31 | -34 | -77 | Upgrade |
Other Unusual Items | 2 | -17 | - | - | - | -25 | Upgrade |
Pretax Income | -255 | -254 | 40 | 149 | 2 | -120 | Upgrade |
Income Tax Expense | 71 | 16 | 5 | -4 | -5 | 31 | Upgrade |
Earnings From Continuing Operations | -326 | -270 | 35 | 153 | 7 | -151 | Upgrade |
Minority Interest in Earnings | - | - | - | - | - | 2 | Upgrade |
Net Income | -326 | -270 | 35 | 153 | 7 | -149 | Upgrade |
Net Income to Common | -326 | -270 | 35 | 153 | 7 | -149 | Upgrade |
Net Income Growth | - | - | -77.12% | 2085.71% | - | - | Upgrade |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Change (YoY) | - | - | - | - | - | -0.53% | Upgrade |
EPS (Basic) | -32.34 | -26.79 | 3.47 | 15.18 | 0.69 | -14.78 | Upgrade |
EPS (Diluted) | -32.34 | -26.79 | 3.47 | 15.18 | 0.69 | -14.78 | Upgrade |
EPS Growth | - | - | -77.12% | 2085.72% | - | - | Upgrade |
Free Cash Flow | - | 42 | 74 | 252 | 146 | 31 | Upgrade |
Free Cash Flow Per Share | - | 4.17 | 7.34 | 25.00 | 14.49 | 3.08 | Upgrade |
Dividend Per Share | - | - | 3.000 | 4.500 | - | - | Upgrade |
Dividend Growth | - | - | -33.33% | - | - | - | Upgrade |
Gross Margin | 50.05% | 49.70% | 51.52% | 50.66% | 46.14% | 46.50% | Upgrade |
Operating Margin | -11.95% | -7.01% | 2.85% | 8.81% | 2.49% | -0.56% | Upgrade |
Profit Margin | -17.02% | -13.42% | 1.69% | 6.94% | 0.36% | -8.29% | Upgrade |
Free Cash Flow Margin | - | 2.09% | 3.57% | 11.44% | 7.57% | 1.72% | Upgrade |
EBITDA | -180.75 | -101 | 88 | 260 | 161 | 79 | Upgrade |
EBITDA Margin | -9.43% | -5.02% | 4.25% | 11.80% | 8.35% | 4.39% | Upgrade |
D&A For EBITDA | 48.25 | 40 | 29 | 66 | 113 | 89 | Upgrade |
EBIT | -229 | -141 | 59 | 194 | 48 | -10 | Upgrade |
EBIT Margin | -11.95% | -7.01% | 2.85% | 8.81% | 2.49% | -0.56% | Upgrade |
Effective Tax Rate | - | - | 12.50% | - | - | - | Upgrade |
Advertising Expenses | - | 307 | 303 | 278 | 236 | 182 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.